Insulin attenuates the stimulatory effects of tumor necrosis factor α on 11β-hydroxysteroid dehydrogenase 1 in human adipose stromal cells

被引:38
|
作者
Handoko, K
Yang, KP
Strutt, B
Khalil, W
Killinger, D [1 ]
机构
[1] Univ Western Ontario, Dept Pharmacol & Toxicol, Lawson Res Inst, St Josephs Hlth Ctr, London, ON N6A 4V2, Canada
[2] Univ Western Ontario, St Josephs Hlth Ctr, Dept Physiol, Lawson Res Inst, London, ON N6A 4V2, Canada
[3] Univ Western Ontario, St Josephs Hlth Ctr, Dept Obstet & Gynecol, Lawson Res Inst, London, ON N6A 4V2, Canada
[4] Univ Western Ontario, St Josephs Hlth Ctr, Dept Med, Lawson Res Inst, London, ON N6A 4V2, Canada
[5] Univ Utrecht, Dept Pharmacol, NL-3584 CA Utrecht, Netherlands
基金
英国医学研究理事会;
关键词
glucocorticoids; type; 2; diabetes; insulin-resistance;
D O I
10.1016/S0960-0760(00)00029-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obesity is frequently associated with insulin-resistance and abnormal glucose homeostasis. Recent evidence indicates that TNF alpha may play a role in mediating the insulin-resistance of obesity through its overexpression in adipose tissue. Previously, we have shown that human adipose stromal cells contain 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) mRNA and activity. The present study was designed to examine the effects of insulin on 11 beta-HSD1 expression in human adipose stromal cells under basal and TNF alpha-stimulated conditions. The cells were obtained from breast adipose tissue by collagenase digestion, and grown to confluence under replicating conditions in 10% fetal bovine serum. The cells were transferred to serum-free medium for 24 h prior to treatment with either TNF alpha, insulin or both for a further 24 h. The level of 11 beta-HSD1 reductase activity was determined by measuring the conversion of [H-3]-cortisone to [H-3]-cortisol at a substrate concentration of 10 nM, Treatment with TNF alpha at concentrations of 0.1-10 ng/ml resulted in a dose dependent increase in 11 beta-HSD1 reductase activity from 1.5 to 10-fold. Insulin (0.1-100 nM) had no effect under basal conditions, but inhibited the stimulatory effects of TNF alpha (5 ng/ml) on 11 beta-HSD1 reductase activity in a dose dependent fashion (8-66%) inhibition. Northern blot analysis revealed corresponding changes in the level of 11 beta-HSD1 mRNA, suggesting that the effects of TNF alpha and insulin on 11 beta-HSD1 activity are mediated at the level of gene transcription. The interaction between insulin and TNF alpha suggests that local and systemic factors may act in a concerted fashion to modulate glucocorticoid activity in adipose and other peripheral tissues. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:163 / 168
页数:6
相关论文
共 27 条
  • [1] 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells
    Lee, Sang Eun
    Lee, Eun Young
    Kang, Sang Jin
    Lee, Seung Hun
    YONSEI MEDICAL JOURNAL, 2017, 58 (06) : 1204 - 1210
  • [2] Ectopic lipid deposition mediates insulin resistance in adipose specific 11β -hydroxysteroid dehydrogenase type 1 transgenic mice
    Abulizi, Abudukadier
    Camporez, Joao-Paulo
    Zhang, Dongyan
    Samuel, Varman T.
    Shulman, Gerald, I
    Vatner, Daniel F.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 93 : 1 - 9
  • [3] 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue and prospective changes in body weight and insulin resistance
    Koska, Juraj
    de Courten, Barbora
    Wake, Deborah J.
    Nair, Saraswathy
    Walker, Brian R.
    Bunt, Joy C.
    Permana, Paska A.
    Lindsay, Robert S.
    Tataranni, P. Antonio
    OBESITY, 2006, 14 (09): : 1515 - 1522
  • [4] Tumor necrosis factor-α upregulates 11β-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-β in HepG2 cells
    Ignatova, Irena D.
    Kostadinova, Radina M.
    Goldring, Christopher E.
    Nawrocki, Andrea R.
    Frey, Felix J.
    Frey, Brigitte M.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 296 (02): : E367 - E377
  • [5] Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance
    Kern, PA
    Ranganathan, S
    Li, CL
    Wood, L
    Ranganathan, G
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 280 (05): : E745 - E751
  • [6] Diabetes and Insulin Injection Modalities: Effects on Hepatic and Hippocampal Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Juvenile Diabetic Male Rats
    Rougeon, Veronica
    Moisan, Marie-Pierre
    Barthe, Nicole
    Beauvieux, Marie-Christine
    Helbling, Jean-Christophe
    Pallet, Veronique
    Marissal-Arvy, Nathalie
    Barat, Pascal
    FRONTIERS IN ENDOCRINOLOGY, 2017, 8
  • [7] Insulin resistance in adipose tissue:: direct and indirect effects of tumor necrosis factor-α
    Ruan, H
    Lodish, HF
    CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (05) : 447 - 455
  • [8] 11-Hydroxy-β-steroid dehydrogenase gene expression in canine adipose tissue and adipocytes: Stimulation by lipopolysaccharide and tumor necrosis factor α
    Ryan, V. H.
    Trayhurn, P.
    Hunter, L.
    Morris, P. J.
    German, A. J.
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2011, 41 (03) : 150 - 161
  • [9] Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice
    Bluemel, Sena
    Wang, Yanhan
    Lee, Suhan
    Schnabl, Bernd
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (33) : 4933 - 4944
  • [10] Glucocorticoid-mediated effects on metabolism are reversed by targeting 11 beta hydroxysteroid dehydrogenase type 1 in human skeletal muscle
    Salehzadeh, Firoozeh
    Al-Khalili, Lubna
    Kulkarni, Sameer S.
    Wang, Minghan
    Lonnqvist, Fredrik
    Krook, Anna
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2009, 25 (03) : 250 - 258